These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8600059)

  • 21. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer.
    Yamamoto H; Sawai H; Weber TK; Rodriguez-Bigas MA; Perucho M
    Cancer Res; 1998 Mar; 58(5):997-1003. PubMed ID: 9500462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary carcinoma: pathogenesis and diagnosis].
    Jungck M
    Zentralbl Chir; 2000; 125 Suppl 1():8-11. PubMed ID: 10929639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
    Lin X; Ramamurthi K; Mishima M; Kondo A; Christen RD; Howell SB
    Cancer Res; 2001 Feb; 61(4):1508-16. PubMed ID: 11245458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editing DNA replication and recombination by mismatch repair: from bacterial genetics to mechanisms of predisposition to cancer in humans.
    Radman M; Matic I; Halliday JA; Taddei F
    Philos Trans R Soc Lond B Biol Sci; 1995 Jan; 347(1319):97-103. PubMed ID: 7746861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma.
    Alvino E; Marra G; Pagani E; Falcinelli S; Pepponi R; Perrera C; Haider R; Castiglia D; Ferranti G; Bonmassar E; Jiricny J; Zambruno G; D'Atri S
    J Invest Dermatol; 2002 Jan; 118(1):79-86. PubMed ID: 11851879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].
    Olschwang S; Bonaïti C; Feingold J; Frébourg T; Grandjouan S; Lasset C; Laurent-Puig P; Lecuru F; Millat B; Sobol H; Thomas G; Eisinger F
    Bull Cancer; 2004 Apr; 91(4):303-15. PubMed ID: 15242312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2F-4 mutation in hereditary non-polyposis colorectal cancer.
    Moriyama H; Sasamoto H; Kambara T; Matsubara N; Ikeda M; Baba S; Meltzer SJ; Lynch HT; Shimizu K; Tanaka N
    J Exp Clin Cancer Res; 2002 Jun; 21(2):185-9. PubMed ID: 12148576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer.
    Hassen S; Ali N; Chowdhury P
    World J Gastrointest Pathophysiol; 2012 Jun; 3(3):71-9. PubMed ID: 22737591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
    Fink D; Nebel S; Norris PS; Aebi S; Kim HK; Haas M; Howell SB
    Br J Cancer; 1998 Mar; 77(5):703-8. PubMed ID: 9514047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mismatch repair and cancer susceptibility.
    Kolodner RD; Alani E
    Curr Opin Biotechnol; 1994 Dec; 5(6):585-94. PubMed ID: 7765740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mismatch repair genes matched to several new roles in cancer.
    Holzman D
    J Natl Cancer Inst; 1996 Jul; 88(14):950-1. PubMed ID: 8667424
    [No Abstract]   [Full Text] [Related]  

  • 33. DNA repair mechanisms in colorectal carcinogenesis.
    Michailidi C; Papavassiliou AG; Troungos C
    Curr Mol Med; 2012 Mar; 12(3):237-46. PubMed ID: 22082485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?
    Mohrenweiser HW; Jones IM
    Mutat Res; 1998 May; 400(1-2):15-24. PubMed ID: 9685572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manipulation of DNA Repair Proficiency in Mouse Models of Colorectal Cancer.
    Mcilhatton MA; Boivin GP; Groden J
    Biomed Res Int; 2016; 2016():1414383. PubMed ID: 27413734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scientists find genes for colorectal cancer, raising hopes for genetic test.
    Strobel G; Dickman S
    Ann Oncol; 1994 Sep; 5(7):562-3. PubMed ID: 7993827
    [No Abstract]   [Full Text] [Related]  

  • 37. Switching off DNA repair-how colorectal cancer evades targeted therapies through adaptive mutability.
    Fahrer J
    Signal Transduct Target Ther; 2020 Feb; 5(1):19. PubMed ID: 32296051
    [No Abstract]   [Full Text] [Related]  

  • 38. And-1 O-GlcNAcylation regulates homologous recombination repair and radioresistance in colorectal cancer.
    Zhou Y; Zhang Y; Peng C; Li Z; Pei H; Pei H; Zhu W
    Clin Transl Med; 2022 Apr; 12(4):e785. PubMed ID: 35474639
    [No Abstract]   [Full Text] [Related]  

  • 39. Mammalian DNA-repair genes.
    Wevrick R; Buchwald M
    Curr Opin Genet Dev; 1993 Jun; 3(3):470-4. PubMed ID: 8353423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of DNA repair: implications for human disease and oncology.
    Bohr VA; Evans MK
    Pediatr Hematol Oncol; 1990; 7(1):47-69. PubMed ID: 2204408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.